This study failed to find differences in other BBB factors between AD-HL and AD-nHL groups, suggesting that MMP-2/MMP-3 might be the important factors indicating BBB damage aggravated by HL in AD patients. This evidence concerns the gene MMP2 and Hodgkins lymphoma.